Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Hyponatremia

quinazolines has been researched along with Hyponatremia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bohra, GK; Kumar, D; Meena, DS; Midha, N1
Bortlicek, Z; Bruha, F; Fiala, O; Minarik, M; Mukensnabl, P; Pesek, M; Racek, J; Svaton, M1
Butler, JS; Donahue, BR; Huang, Y; Olmez, I; Rubin, P; Xu, Y1
Boku, N; Brown, KH; Hayashi, H; Muro, K; Nakajima, TE; Satoh, T; Shi, X; Shimada, Y; Takahari, D; Taku, K; Yamada, Y1
Agnoli, GC; Borgatti, R; Cacciari, M; Dorigoni, S; Garutti, C; Ikonomu, E; Lenzi, P1
Hillenbrand, P; Sherlock, S1

Trials

1 trial(s) available for quinazolines and Hyponatremia

ArticleYear
Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite; Area Under Curve; Asian People; Capecitabine; Cisplatin; Deoxycytidine; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Hyponatremia; Japan; Male; Metabolic Clearance Rate; Middle Aged; Neutropenia; Oxonic Acid; Quinazolines; Stomach Neoplasms; Tegafur; Treatment Outcome; Tumor Burden

2012

Other Studies

5 other study(ies) available for quinazolines and Hyponatremia

ArticleYear
Gefitinib induced severe hyponatremia: A case report.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:3

    Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Gefitinib; Humans; Hyponatremia; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines

2021
Predictive and prognostic significance of sodium levels in patients with NSCLC treated by erlotinib.
    Anticancer research, 2014, Volume: 34, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Sodium; Treatment Outcome

2014
Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis.
    Lung cancer (Amsterdam, Netherlands), 2010, Volume: 70, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease Progression; Drug Interactions; Erlotinib Hydrochloride; Female; Humans; Hyponatremia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Quinazolines; Treatment Outcome; Whole-Body Irradiation

2010
[Low-dose dopamine as an activator of renal catecholamine receptors of different classes. II. Studies in water-saline depletion and associated adrenergic blockade].
    Bollettino della Societa italiana di biologia sperimentale, 1984, Oct-30, Volume: 60, Issue:10

    Topics: Dopamine; Hemodynamics; Humans; Hyponatremia; Kidney; Natriuresis; Polyuria; Prazosin; Quinazolines; Receptors, Adrenergic, beta; Water Deprivation

1984
Use of metolazone in the treatment of ascites due to liver disease.
    British medical journal, 1971, Oct-30, Volume: 4, Issue:5782

    Topics: Adult; Ascites; Chlorides; Chronic Disease; Diuretics; Female; Hepatic Encephalopathy; Humans; Hypokalemia; Hyponatremia; Ketones; Liver Diseases; Male; Middle Aged; Nitrogen; Pyrazines; Quinazolines; Spironolactone; Sulfonamides; Uremia

1971